This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Parliament is calling for regulators to audit pharmaceuticalcompanies that have made misleading statements to the public about their Covid-19 vaccines. A member of the U.K. And the move comes after Moderna was chastised for the second time in five months by a U.K.
This article explores how pharmaceuticalcompanies are leveraging AI and focusing on orphan drugs to tackle rare diseases. To effectively combat rare diseases, it is essential to prioritise the collection and analysis of data.
Pharmaceuticalcompanies are increasingly focusing on radiopharmaceuticals due to their potential in oncology and therapeutic applications. Learn more about why the industry is excited about radioisotopes in this article.
The race for obesity drug assets is becoming more intense as pharmaceuticalcompanies strive to develop effective treatments for weight loss. This article explores the efficacy, potential sales, and market trends in the field of obesity drugs.
We revisit a favorite topic, sustainability—and will be updating our coverage of this topic with the upcoming March-April 2023 issue of Pharmaceutical Engineering. It is the result of more than two years of collaboration between the company corporate teams, individual site teams, and an external specialist consultant.
In order to succeed in this challenging environment, pharmaceuticalcompanies need to adopt a patient-centric approach to marketing. Patient-centric pharmaceutical marketing is based on the understanding that patients are more than just consumers of drugs. It is also about changing the mindset of pharmaceuticalcompanies.
What pharmacists should know about the blockbuster drugs of 2023 Blockbuster drugs are medications that generate significant annual revenue ($1 billion or more) for pharmaceuticalcompanies. In this article, we look at five red flags to watch for controlled medication abuse and how to approach the issue with compassion.
With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceuticalcompanies and healthcare brands are allocating more resources to advertising in 2025. Regulatory agencies are demanding clearer disclosures and evidence-based claims in pharmaceutical promotions.
The proportion of pharmaceuticalcompanies hiring for AI related positions kept relatively steady in May 2022 compared with the equivalent month last year, with 39.3% of the companies included in our analysis recruiting for at least one such position. in April 2022.
This article explores the key metrics pharma marketing teams should prioritize to drive success. Unlike traditional consumer brands, pharmaceuticalcompanies face unique challenges on social media, including strict regulations, compliance concerns, and the need for factual accuracy.
Traditionally, pharmaceuticalcompanies have relied on demographics to target their marketing efforts. To create truly effective marketing campaigns, pharmaceuticalcompanies need to go beyond demographics and consider the psychographics of their target audience. Goals: What are consumers trying to achieve?
Sponsorships can be a powerful tool for pharmaceuticalcompanies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceuticalcompanies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way.
… Almost a dozen pharmaceuticalcompanies have lost sensitive customer data due to a supply chain cyberattack that trickled down from Cencora , TechRadar writes. Our choice today is hot buttery rum. As always, you are invited to join us. We hope your day is productive and meaningful. Either way, do keep in touch.
This is especially true when it comes to pharmaceutical-sponsored health information. Pharmaceuticalcompanies have a vested interest in promoting their products, so it’s important to be critical of any information they put out. This article was produced with the assistance of artificial intelligence.
In total, the frequency of sentences related to cloud computing between April 2021 and March 2022 was 133% higher than in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings. Other top employers with high cloud mentions included GSK, Roche and Pfizer.
But in order to be truly effective, sponsorships must be aligned with a company’s brand values. For pharmaceuticalcompanies, this means aligning sponsorships with causes that are related to health and wellness. In 2020, the company committed to investing $5 billion in research and development over the next five years.
The proportion of pharmaceuticalcompanies hiring for machine learning related positions rose in June 2022 compared with the equivalent month last year, with 26.4% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 24.1% in May 2022.
This allows for streamlined regulatory processes and a reduced administration load for both pharmaceuticalcompanies and health authorities, according to the paper. Use of ePI will also benefit medicine availability in small markets, supporting a more flexible supply chain, according to the paper.
In this article, we’ll explore 10 innovative trends in pharma marketing that can set you up for success in this rapidly evolving landscape. By 2025, pharmaceuticalcompanies will need to adapt and innovate to remain competitive and effectively reach their target audiences.
The pharmaceutical industry is constantly evolving, and digital technology is playing an increasingly important role in marketing campaigns. In the past, pharmaceuticalcompanies relied heavily on traditional marketing methods such as print ads, TV commercials, and direct mail.
Here are some factors to consider when choosing a web development company for the pharmaceutical industry: ● Experience in the pharmaceutical industry: Make sure the company you choose has experience developing websites for pharmaceuticalcompanies. Interview multiple companies before making a decision. ●
Despite untold investment by numerous pharmaceuticalcompanies, FDA-approved drugs that target critical brain functions and conditions like anxiety, depression, and sedation continue to present severe and unpredictable side effects, including suicidal ideation.
Sponsorships can be a powerful tool for pharmaceuticalcompanies to engage with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. But with so many different healthcare organizations and causes to choose from, it can be difficult to know where to start.
This article explores how to develop and optimize paid social media campaigns that drive engagement while staying compliant. Disease awareness campaigns can also reach specific patient groups based on demographics and interests, helping pharmaceuticalcompanies create more personalized outreach. In the U.S.,
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceuticalcompanies. Value in healthcare is a continually changing concept. The post Responding to dynamic shifts in value communications appeared first on.
” Implementing quality standards for medicinal cannabis Mikael Sodergren of Curaleaf International explained in an article published on EPR’s website last month: “there is a vast range of flavonoids, terpenoids, phytols and other compounds present at lower concentrations within the cannabis flower”.
However, inefficiencies in the high cost, unsustainable process could limit patient access to oligonucleotide-based therapeutics at a large scale, CPI acknowledged. “Many pharmaceuticalcompanies have rich pipelines of oligonucleotide-based drug candidates that could benefit from an alternative production process.
The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled. However, in recent years, there has been a noticeable decline in the number of these letters being issued.
A single chromatograph produces about a liter of liquid waste, according to the researchers, with some major pharmaceuticalcompanies operating more than 1,000 chromatographic studies per day. Editors and reviewers of the peer-reviewed journal Green Chemistry have highlighted the study as one of its “hot” articles for 2023.
Now, the major advance that’s available to pharmaceuticalcompanies is in the amount and range of data they have access to and how it can be applied to the risk-based monitoring and remote monitoring of studies. • Read the full article in pharmaphorum’s Deep Dive digital magazine.
As new approaches to healthcare attainment take hold there will be some degree of uncertainty among pharmaceuticalcompanies about where they fit into the new structures and the holistic care they seek to provide.
The pharmaceutical industry is increasingly turning to e-commerce to reach new customers and expand their sales. E-commerce strategies are essential for pharmaceuticalcompanies to maximize their online sales and stay ahead of the competition.
The proportion of pharmaceuticalcompanies hiring for artificial intelligence related positions dropped in October 2022 compared with the equivalent month last year, with 37.4% of the companies included in our analysis recruiting for at least one such position. This latest figure was lower than the 38.6% in September 2022.
Pharmaceuticalcompanies ask themselves this question before embracing the latest technologies because every innovation comes with both opportunities and risks. According to recent estimates, the opportunity from generative AI alone could produce up to $110 billion in annual value across the pharmaceutical industry value chain.
In this article, Ben Hargreaves looks at how VR headsets are being used to better educate both healthcare professionals and the general public. This has not escaped the notice of pharmaceuticalcompanies looking to educate patients on topics, with which they may not have the most health literacy. In reality.
Social media platforms can be a great way for pharmaceuticalcompanies to connect with their target audience and promote their products or services. You can use LinkedIn to share news about your company, post job openings, and connect with potential customers.
For example, a pharmaceuticalcompany could create a blog post about a new drug that it is developing. For example, a pharmaceuticalcompany could create a white paper about a particular medical condition. For example, a pharmaceuticalcompany could create a video about one of its products and share it on YouTube.
A 2017 article in Health Policy estimates that the cost of developing an antibiotic is around $1.5bn, while according to a 2020 article in Nature, the average revenue generated from an antibiotic’s sale is about $46m a year. The most significant challenge, however, is solving the lack of market incentive.
Weight loss has been an essential area in which many pharmaceuticalcompanies have made interventions by providing effective medications that can assist patients dealing with obesity. In this article, we will compare the newly approved weight loss medication Zepbound to a diabetes medication called Mounjaro.
This article will explore some of the factors that organisations in the pharmaceutical sector should be considering in advance of the new system coming into effect. The Unitary Patent. There are some clear advantages to the unitary patent right. Additionally, enforcement should be simpler and more cost-effective than before.
This means the revenue clawback rate paid by pharmaceuticalcompanies subject to the Statutory Scheme for branded medicines will increase from 24.4 The Association of the British Pharmaceutical Industry (ABPI) and Lilly and Company have responded, emphasising the plans are not supportive to life sciences sector. “We
The proportion of pharmaceuticalcompanies hiring for big data related positions rose in June 2022 compared with the equivalent month last year, with 68.4% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 65.7% in May 2022.
In the fast-paced, highly competitive pharmaceutical industry, sales reps must adapt to new ways of engaging with customers and healthcare professionals (HCPs).
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content